Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Summary
Dr. Marty Makary is stepping down as the head of the Food and Drug Administration (FDA) after just over a year in charge. His time at the agency saw conflicts with drug companies, vaping supporters, and anti-abortion groups, along with internal staff departures and concerns about politics affecting scientific decisions.Key Facts
- Dr. Marty Makary has been the FDA commissioner for a bit more than one year.
- He faced criticism from pharmaceutical leaders, vaping lobbyists, and anti-abortion activists.
- Many senior FDA officials left or were removed in the first year of President Trump’s second term.
- Makary’s deputy, Dr. Vinay Prasad, was forced out twice after upsetting drugmakers and patient groups.
- The agency experienced low morale, leaks, and stories about internal problems.
- Kyle Diamantas, the FDA’s chief for foods, will serve as acting commissioner after Makary leaves.
- Makary was known for criticizing COVID-19 health measures on Fox News before leading the FDA.
- The FDA struggled to balance political pressures with scientific decisions during his leadership.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.